Patents by Inventor Lynn D. Hawkins

Lynn D. Hawkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunomodulatory compounds and methods of use thereof
    Publication number: 20030153532
    Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.
    Type: Application
    Filed: July 31, 2002
    Publication date: August 14, 2003
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuinness, Jeffrey Rose
  • Immunological adjuvant compounds compositions and methods of use thereof
    Patent number: 6551600
    Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: April 22, 2003
    Assignee: Eisai Co., Ltd.
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuiness, Jeffrey Rose
  • Immunological adjuvant compounds compositions and methods of use thereof
    Patent number: 6521776
    Abstract: The present invention provides novel compounds that function as immunological adjuvants when co-administered with antigens, including, antigens used as vaccines for any disease or condition amenable to vaccination. The invention also provides adjuvant formulations comprising the novel compounds of the invention and methods for immunizing humans and non-human animals.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: February 18, 2003
    Assignee: Eisai Company, Limited
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Jeffrey Rose, Hu Yang
  • Immunological adjuvant compounds compositions and methods of use thereof
    Publication number: 20020176861
    Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.
    Type: Application
    Filed: July 31, 2001
    Publication date: November 28, 2002
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuinness, Jeffrey Rose
  • Immunological adjuvant compounds compositions and methods of use thereof
    Publication number: 20020049314
    Abstract: The present invention provides novel compounds that function as immunological adjuvants when co-administered with antigens, including, antigens used as vaccines for any disease or condition amenable to vaccination. The invention also provides adjuvant formulations comprising the novel compounds of the invention and methods for immunizing humans and non-human animals.
    Type: Application
    Filed: July 30, 2001
    Publication date: April 25, 2002
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuiness, Jeffrey Rose
  • Immunological adjuvant compounds, compositions, and methods of use thereof
    Patent number: 6290973
    Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: September 18, 2001
    Assignee: Eisai Co., Ltd.
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuiness, Anneliese Nault, Jeffrey Rose, Daniel P. Rossignol
  • Anti-endotoxin compounds
    Patent number: 5843918
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 1, 1998
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano
  • Anti-endotoxin compounds
    Patent number: 5756718
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 26, 1998
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano
  • Anti-endotoxin compounds
    Patent number: 5612476
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 18, 1997
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano
  • Anti-endotoxin compounds
    Patent number: 5530113
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: August 25, 1992
    Date of Patent: June 25, 1996
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano
  • Trisubstituted phenyl analogs having activity for congestive heart failure
    Patent number: 5274002
    Abstract: Novel trisubstituted phenyl analogs are now found to have activity as for the treatment of congestive heart failure.
    Type: Grant
    Filed: September 6, 1990
    Date of Patent: December 28, 1993
    Assignee: Warner-Lambert Company
    Inventor: Lynn D. Hawkins
  • Trisubstituted phenyl analogs having activity for congestive heart failure
    Patent number: 4971959
    Abstract: Novel trisubstituted phenyl analogs are now found to have activity as for the treatment of congestive heart failure.
    Type: Grant
    Filed: December 30, 1988
    Date of Patent: November 20, 1990
    Assignee: Warner-Lambert Company
    Inventor: Lynn D. Hawkins